Akums Drugs and Pharmaceuticals (NSE:AKUMS) Marketable Securities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Akums Drugs and Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Akums Drugs and Pharmaceuticals's annual Marketable Securities increased from Mar. 2022 (₹482 Mil) to Mar. 2023 (₹989 Mil) and increased from Mar. 2023 (₹989 Mil) to Mar. 2024 (₹1,768 Mil).

Akums Drugs and Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals Marketable Securities Chart

Akums Drugs and Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Marketable Securities

653.18

481.56

988.92

1,767.72

Akums Drugs and Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial			1,293.15	-	1,767.72	3,422.92	-

Akums Drugs and Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Akums Drugs and Pharmaceuticals (NSE:AKUMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Akums Drugs and Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Akums Drugs and Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (NSE:AKUMS) » Definitions » Marketable Securities

Traded in Other Exchanges

544222:India

Address

Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083

Website

https://www.akums.in

Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines